Selective Deletion of the NH2-terminal Variable Region of Cardiac Troponin T in Ischemia Reperfusion by Myofibril-associated Mu-calpain Cleavage
Overview
Affiliations
The structure of the NH2-terminal region of troponin T (TnT) is hypervariable among the muscle type-specific isoforms and is also regulated by alternative RNA splicing. This region does not contain binding sites for other thin filament proteins, but alteration of its structure affects the Ca2+ regulation of muscle contraction. Here we report a truncated cardiac TnT produced during myocardial ischemia reperfusion. Amino acid sequencing and protein fragment reconstruction determined that it is generated by a posttranslational modification selectively removing the NH2-terminal variable region and preserving the conserved core structure of TnT. Triton X-100 extraction of cardiac muscle fibers promoted production of the NH2-terminal truncated cardiac TnT (cTnT-ND), indicating a myofibril-associated proteolytic activity. Mu-calpain is a myofibril-associated protease and is known to degrade TnT. Supporting a role of mu-calpain in producing cTnT-ND in myocardial ischemia reperfusion, calpain inhibitors decreased the level of cTnT-ND in Triton-extracted myofibrils. Mu-calpain treatment of the cardiac myofibril and troponin complex specifically reproduced cTnT-ND. In contrast, mu-calpain treatment of isolated cardiac TnT resulted in nonspecific degradation, suggesting that this structural modification is relevant to physiological structures of the myofilament. Triton X-100 treatment of transgenic mouse cardiac myofibrils overexpressing fast skeletal muscle TnT produced similar NH2-terminal truncations of the endogenous and exogenous TnT, despite different amino acid sequences at the cleavage site. With the functional consequences of removing the NH2-terminal variable region of TnT, the mu-calpain-mediated proteolytic modification of TnT may act as an acute mechanism to adjust muscle contractility under stress conditions.
The roles of intracellular proteolysis in cardiac ischemia-reperfusion injury.
Hartley B, Bassiouni W, Schulz R, Julien O Basic Res Cardiol. 2023; 118(1):38.
PMID: 37768438 DOI: 10.1007/s00395-023-01007-z.
Ronca F, Raggi A Mol Cell Biochem. 2023; 479(4):793-809.
PMID: 37184757 PMC: 11016001. DOI: 10.1007/s11010-023-04763-7.
Monoclonal Antibodies as Probes to Study Ligand-Induced Conformations of Troponin Subunits.
Rasmussen M, Jin J Front Physiol. 2022; 13:828144.
PMID: 35399275 PMC: 8990283. DOI: 10.3389/fphys.2022.828144.
Reversing mitochondrial defects in aged hearts: role of mitochondrial calpain activation.
Chen Q, Thompson J, Hu Y, Lesnefsky E Am J Physiol Cell Physiol. 2022; 322(2):C296-C310.
PMID: 35044856 PMC: 8836732. DOI: 10.1152/ajpcell.00279.2021.
NH-Terminal Cleavage of Cardiac Troponin I Signals Adaptive Response to Cardiac Stressors.
Warren C, Halas M, Feng H, Wolska B, Jin J, Solaro R J Cell Signal. 2021; 2(3):162-171.
PMID: 34541579 PMC: 8444995.